| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
120,416,000 |
| Market
Cap: |
1.47(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$5.3 - $18 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 11.2 |
| Insider 3/6 Months : 11.8 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Atara Biotherapeutics is engaged in T-cell immunotherapy, using its allogeneic Epstein-Barr virus (EBV) T-cell platform to develop therapies for patients with diseases, including tumors, hematologic cancers and autoimmune disease. Co.'s platform utilizes the biology of EBV T cells and has the capability to treat a range of EBV-driven diseases or other diseases through incorporation of engineered chimeric antigen receptors or T-cell receptors. Co.'s T-cell immunotherapy program, tab-cel® (tabelecleucel), is partnered with Pierre Fabre Medicament and is in Phase 3 development for patients with EBV-driven post-transplant lymphoproliferative disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
74,335 |
74,335 |
74,335 |
| Total Buy Value |
$0 |
$856,795 |
$856,795 |
$856,795 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
2 |
2 |
2 |
| Total Shares Sold |
4,719 |
9,486 |
20,581 |
300,055 |
| Total Sell Value |
$62,225 |
$117,594 |
$193,940 |
$463,183 |
| Total People Sold |
2 |
2 |
4 |
6 |
| Total Sell Transactions |
2 |
4 |
9 |
27 |
| End Date |
2025-09-04 |
2025-06-03 |
2024-12-03 |
2023-12-04 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Huang James |
|
– • • |
2025-11-28 |
4 |
D |
$14.03 |
$14 |
I/I |
(1) |
48,736 |
|
- |
|
| Huang James |
|
– • • |
2025-11-28 |
4 |
OE |
$0.00 |
$5 |
I/I |
48,737 |
48,737 |
|
- |
|
| Nguyen Anhco |
President and CEO |
• • – |
2025-11-17 |
4 |
S |
$13.19 |
$38,437 |
D/D |
(2,915) |
64,974 |
|
-15% |
|
| Grant-Huerta Yanina |
Chief Accounting Officer |
• • – |
2025-11-17 |
4 |
S |
$13.19 |
$23,788 |
D/D |
(1,804) |
33,454 |
|
-15% |
|
| Grant-Huerta Yanina |
Chief Accounting Officer |
• • – |
2025-08-18 |
4 |
S |
$11.61 |
$21,009 |
D/D |
(1,809) |
35,258 |
|
-32% |
|
| Nguyen Anhco |
President and CEO |
• • – |
2025-08-18 |
4 |
S |
$11.61 |
$34,360 |
D/D |
(2,958) |
67,889 |
|
-32% |
|
| Huang James |
|
– • • |
2025-08-15 |
4 |
B |
$12.19 |
$670,423 |
I/I |
55,000 |
1,405,000 |
0.01 |
23% |
|
| Huang James |
|
– • • |
2025-07-17 |
4 |
B |
$9.64 |
$186,372 |
I/I |
19,335 |
1,350,000 |
0.01 |
41% |
|
| Touchon Pascal |
|
• • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,828 |
77,955 |
|
- |
|
| Fust Matthew K |
|
• • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,828 |
18,188 |
|
- |
|
| Gallagher Carol Giltner |
|
• • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,828 |
33,012 |
|
- |
|
| Roncarolo Maria Grazia |
|
• • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,828 |
17,368 |
|
- |
|
| Mallik Ameet |
|
• • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,828 |
16,928 |
|
- |
|
| Heiden William K |
|
• • – |
2025-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
7,828 |
22,188 |
|
- |
|
| Green Jeremy |
Director |
– • – |
2025-05-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
441,701 |
|
102% |
|
| Huang James |
|
– • • |
2025-05-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,330,665 |
|
102% |
|
| Grant-Huerta Yanina |
Chief Accounting Officer |
• • – |
2025-05-16 |
4 |
S |
$6.76 |
$15,000 |
D/D |
(2,218) |
37,067 |
|
-102% |
|
| Nguyen Anhco |
President and CEO |
• • – |
2025-05-16 |
4 |
S |
$6.76 |
$22,156 |
D/D |
(3,276) |
70,847 |
|
-102% |
|
| Ciongoli Gregory Austin |
See remarks |
– • • |
2025-05-16 |
4 |
A |
$6.61 |
$499,531 |
D/D |
75,572 |
1,209,395 |
|
- |
|
| Grant-Huerta Yanina |
Chief Accounting Officer |
• – – |
2025-03-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
39,285 |
|
84% |
|
| Henrich Jill |
EVP, Chief Regulatory Officer |
• • – |
2025-03-03 |
4 |
S |
$7.00 |
$7,410 |
D/D |
(1,059) |
18,679 |
|
-32% |
|
| Hyllengren Eric J |
EVP, CFO and COO |
• • – |
2025-03-03 |
4 |
S |
$7.00 |
$8,473 |
D/D |
(1,211) |
56,231 |
|
-32% |
|
| Nguyen Anhco |
President and CEO |
• • – |
2025-03-03 |
4 |
S |
$7.00 |
$23,307 |
D/D |
(3,331) |
74,123 |
|
-32% |
|
| Hyllengren Eric J |
EVP, CFO and COO |
• • – |
2025-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
34,050 |
57,442 |
|
- |
|
| Hyllengren Eric J |
EVP, CFO and COO |
• • – |
2024-11-18 |
4 |
S |
$11.20 |
$15,274 |
D/D |
(1,364) |
23,392 |
|
47% |
|
667 Records found
|
|
Page 1 of 27 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
1.32 (9.75%) 
